Andrew Scott discusses his experiences with the YO Committee, which came to an end at the SOE 2019. Dr Scott also previews the coming years, his achievements, and the SOE session he presented at SOE on Saturday.
1. SOE 2019 was the end of your involvement with the SOE YO Committee. What were your highlights & what are you expecting to see in ophthalmology in the coming years? (0:04)
2. What are your best achievements as part of the YO Committee? (2:15)
3. Tell us about your YO session that you presented at SOE this year? (3:08)
Filmed in partnership with the European Society of Ophthalmology (SOE) at the SOE 2019 meeting in Nice, France.
Share this Video
Related Videos In Anterior Segment
Chhavi Saini, ASCRS 2022: Clinical outcomes of Boston keratoprosthesis type 2
The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr […]
Eduardo Roditi, ASCRS 22: Topical timolol 0.25% to enhance preoperative reference vessels image in digitally assisted intraoperative axis alignment for toric IOL
When capturing a scleral image in the biometry occasionally an error message can appear as “not enough vessels near the limbus have been found”, in consequence, using the intraoperative toric axis assistant is not possible. Timolol 0.25% is a common and available non-selective beta-adrenergic blocker. The use of topical timolol 0.25% drops as an effective […]
Christopher Lievens, ARVO 2022: GEMINI 1 and GEMINI 2 pooled phase 3 studies: extended depth of focus from AGN-190584
The clinical outcomes of the GEMINI 1 and GEMINI 2 studies are discussed in this touchOPHTHALMOLOGY interview with Prof. Christopher Lievens (Southern College of Optometry, Memphis, Tennessee, USA). If approved, AGN-190584 is expected to be the first eye drop for the treatment of presbyopia, the eye’s reduced ability to focus on near objects. The presentation […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!